Nhắm vào P-glycoprotein: Một chiến lược độc đáo để loại bỏ chọn lọc các tế bào T phản ứng miễn dịch

Goldman, 1988, Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion., Ann Intern Med., 108, 806, 10.7326/0003-4819-108-6-806 Champlin, 1990, T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation., Hematol Oncol Clin North Am., 4, 687, 10.1016/S0889-8588(18)30486-6 Aversa, 1998, Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype., N Engl J Med., 339, 1186, 10.1056/NEJM199810223391702 Storek, 2000, T-cell reconstitution after stem-cell transplantation—by which organ., Lancet., 355, 1843, 10.1016/S0140-6736(00)02284-4 Appelbaum, 2001, Haematopoietic cell transplantation as immunotherapy., Nature., 411, 385, 10.1038/35077251 Gratama, 2001, Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection., Blood., 98, 1358, 10.1182/blood.V98.5.1358 van Esser, 2001, Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT., Blood., 98, 972, 10.1182/blood.V98.4.972 Urbano-Ispizua, 2001, The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings., Blood., 97, 383, 10.1182/blood.V97.2.383 Pollard, 1986, Leukaemic relapse after Campath 1 treated bone marrow transplantation for leukaemia., Lancet., 2, 1343, 10.1016/S0140-6736(86)91482-0 Marmont, 1991, T-cell depletion of HLA-identical transplants in leukemia., Blood., 78, 2120, 10.1182/blood.V78.8.2120.2120 Yu, 2001, Anti-CD3 epsilon F(ab′)2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens., J Immunol., 166, 5835, 10.4049/jimmunol.166.9.5835 Guinan, 1999, Transplantation of anergic histoincompatible bone marrow allografts., N Engl J Med., 340, 1704, 10.1056/NEJM199906033402202 Greenberg, 1999, Deficient cellular immunity-finding and fixing the defects., Science., 285, 546, 10.1126/science.285.5427.546 Champlin, 1990, Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation., Blood., 76, 418, 10.1182/blood.V76.2.418.418 Soiffer, 1997, CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission., Blood., 89, 3039, 10.1182/blood.V89.8.3039 Soiffer, 2001, CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors., J Clin Oncol., 19, 1152, 10.1200/JCO.2001.19.4.1152 Roy, 1990, Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium., Blood., 75, 296, 10.1182/blood.V75.1.296.296 Alyea, 2001, T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect., Blood., 98, 934, 10.1182/blood.V98.4.934 Krenger, 1997, Cytokine cascades in acute graft-versus-host disease., Transplantation., 64, 553, 10.1097/00007890-199708270-00001 Martin, 1999, A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients., Blood., 94, 2192, 10.1182/blood.V94.7.2192.419a38_2192_2199 Koh, 1999, Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis., Bone Marrow Transplant., 23, 1071, 10.1038/sj.bmt.1701749 Montagna, 1999, Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity., Blood., 93, 3550, 10.1182/blood.V93.10.3550.410k24_3550_3557 Garderet, 1999, Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations., Transplantation., 67, 124, 10.1097/00007890-199901150-00021 Mavroudis, 1996, Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation., Bone Marrow Transplant., 17, 793 Fehse, 2000, Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69)., Br J Haematol., 109, 644, 10.1046/j.1365-2141.2000.02074.x Weaver, 1991, Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells., Exp Cell Res., 196, 323, 10.1016/0014-4827(91)90267-X Chaudhary, 1992, Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes., Blood., 80, 2735, 10.1182/blood.V80.11.2735.bloodjournal80112735 Ludescher, 1998, Differential activity of P-glycoprotein in normal blood lymphocyte subsets., Br J Haematol., 101, 722, 10.1046/j.1365-2141.1998.00751.x Pilarski, 1995, Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging., Am J Hematol., 49, 323, 10.1002/ajh.2830490411 Coon, 1991, Multidrug resistance activity in human lymphocytes., Hum Immunol., 32, 134, 10.1016/0198-8859(91)90110-U Villeneuve, 1999, Ex vivo photodynamic purging in chronic myelogenous leukaemia and other neoplasias with rhodamine derivatives., Biotechnol Appl Biochem., 30, 1, 10.1111/j.1470-8744.1999.tb01153.x Roy, 1999, Elimination of chronic myeloid leukemia cells with a novel photodynamic treatment., Blood., 94, 144a Roy, 2000, Phase I study of autologous progenitor cell transplantation purged with a photodynamic approach for patients with chronic myeloid leukemia., Blood., 96, 583a Pal, 1996, Phototoxicity of some bromine-substituted rhodamine dyes: synthesis, photophysical properties and application as photosensitizers., Photochem Photobiol., 63, 161, 10.1111/j.1751-1097.1996.tb03008.x Guimond, 2000, Specific elimination of anti-host T cell alloreactivity using a photodynamic approach [abstract]., FASEB J., 14, A1074 Brochu, 1995, Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras., J Immunol., 155, 5104, 10.4049/jimmunol.155.11.5104 Moretta, 1983, Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations., J Exp Med., 158, 571, 10.1084/jem.158.2.571 Roy, 1996, Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin., J Natl Cancer Inst., 88, 1136, 10.1093/jnci/88.16.1136 Guimond, 2000, Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations., Br J Haematol., 109, 130, 10.1046/j.1365-2141.2000.01961.x Pallis, 1999, Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia., Br J Haematol., 104, 307, 10.1046/j.1365-2141.1999.01157.x Huet, 1998, Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network., Cytometry., 34, 248, 10.1002/(SICI)1097-0320(19981215)34:6<248::AID-CYTO2>3.0.CO;2-X Taswell, 1987, A solution to the problems of cytolysis assays with additional applications to other immunological and biochemical assays., J Immunol., 138, 333, 10.4049/jimmunol.138.2.333 Legrand, 1999, Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia., Blood., 94, 1046, 10.1182/blood.V94.3.1046.415k03_1046_1056 Leith, 1999, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study., Blood., 94, 1086 Lehne, 1999, Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents., Leukemia., 13, 768, 10.1038/sj.leu.2401392 Champlin, 2000, T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities., Blood., 95, 3996 Mirshahidi, 2001, Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor., J Exp Med., 194, 719, 10.1084/jem.194.6.719 Wells, 2001, Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy., J Clin Invest., 108, 895, 10.1172/JCI13220 de St Groth, 2001, DCs and peripheral T cell tolerance., Semin Immunol., 13, 311, 10.1006/smim.2001.0327 Iwashiro, 2001, Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection., Proc Natl Acad Sci U S A., 98, 9226, 10.1073/pnas.151174198 Yu, 2001, Advances in transplantation tolerance., Lancet., 357, 1959, 10.1016/S0140-6736(00)05068-6 Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance., Immunol Rev., 182, 18, 10.1034/j.1600-065X.2001.1820102.x Ng, 2001, Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells., Blood., 98, 2736, 10.1182/blood.V98.9.2736 Baecher-Allan, 2001, CD4+CD25high regulatory cells in human peripheral blood., J Immunol., 167, 1245, 10.4049/jimmunol.167.3.1245 Taylor, 2001, CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade., J Exp Med., 193, 1311, 10.1084/jem.193.11.1311 Lowenberg, 1986, Graft-versus-host disease following transplantation of “one log” versus “two log” T-lymphocyte-depleted bone marrow from HLA-identical donors., Bone Marrow Transplant., 1, 133 Roux, 2000, Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity., Blood., 96, 2299, 10.1182/blood.V96.6.2299 Maury, 2001, Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice., Blood., 98, 3156, 10.1182/blood.V98.10.3156 Hochberg, 2001, Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults., Blood., 98, 1116, 10.1182/blood.V98.4.1116 Heemskerk, 2001, Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex., Proc Natl Acad Sci U S A., 98, 6806, 10.1073/pnas.111162298 Basu, 2000, Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR., J Immunol., 164, 5788, 10.4049/jimmunol.164.11.5788 Mutis, 1997, HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells., Blood., 90, 1083, 10.1182/blood.V90.3.1083 Mavroudis, 1998, Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions., Br J Haematol., 101, 565, 10.1046/j.1365-2141.1998.00748.x Ruggeri, 1999, Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation., Blood., 94, 333, 10.1182/blood.V94.1.333.413a31_333_339 Perreault, 1998, Immunodominant minor histocompatibility antigens: the major ones., Immunol Today., 19, 69, 10.1016/S0167-5699(97)01185-7 Martin, 1996, Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism., Blood., 88, 962, 10.1182/blood.V88.3.962.962 Fowler, 2000, Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma., Leuk Lymphoma., 38, 221, 10.3109/10428190009087014 Anel, 1990, Fatty acid metabolism in human lymphocytes, I: time-course changes in fatty acid composition and membrane fluidity during blastic transformation of peripheral blood lymphocytes., Biochim Biophys Acta., 1044, 323, 10.1016/0005-2760(90)90076-A Utsunomiya, 1986, Early transmembrane events in alloimmune cytotoxic T-lymphocyte activation as revealed by stopped-flow fluorometry., Proc Natl Acad Sci U S A., 83, 1877, 10.1073/pnas.83.6.1877 Kessel, 1995, Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent., Br J Cancer., 71, 306, 10.1038/bjc.1995.61 Kim, 1998, Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux., Blood., 91, 4106, 10.1182/blood.V91.11.4106 Slavin, 1996, Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation., Blood., 87, 2195, 10.1182/blood.V87.6.2195.bloodjournal8762195 van Rhee, 1995, Donor leukocyte transfusions for leukemic relapse., Curr Opin Hematol., 2, 423, 10.1097/00062752-199502060-00005 Vogt, 2000, UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition., Blood., 96, 3126, 10.1182/blood.V96.9.3126 Verburg, 2001, High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy., Arthritis Rheum., 44, 754, 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N French, 2001, Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis., Arch Dermatol., 137, 1309, 10.1001/archderm.137.10.1309 Greinix, 2000, Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study., Blood., 96, 2426, 10.1182/blood.V96.7.2426 Barr, 1998, Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group., N Engl J Med., 339, 1744, 10.1056/NEJM199812103392404